Clinical Trial

Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence

Study acronym: FRBN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This pilot randomized controlled trial will investigate the feasibility and effectiveness of using generative artificial intelligence to create personalized therapeutic scripts for imagery rescripting (ImRs). Eighty participants will listen to autobiographical scenarios based on their own memories of childhood criticism and neutral events. The scenarios will be generated by the Gemini large language model and reviewed by trained experimenters. On Day 1, all participants will be exposed to both critical and neutral scenarios and randomly assigned to either an experimental group receiving an ImRs intervention or a control group receiving no therapeutic modification. Skin conductance and subjective emotional ratings will be collected during the session, with follow-up questionnaires administered one week later. In addition, cognitive-behavioral therapists will evaluate the quality of the generated scripts. The study aims to assess emotional and physiological responses to AI-generated content, compare outcomes between groups, and explore the potential of large language models in scalable psychological interventions.
Trial Details
NCT Number NCT07189715
Lead Sponsor University of Social Sciences and Humanities, Warsaw
Conditions Generalized Anxiety, Fear of Failure, Rumination
Enrollment 80 participants
Start Date 2025-06-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-24